Drug and Therapeutics Committees make important decisions about which medicines are approved for use in hospitals, health systems and reimbursed by insurers.  Lisa Bero, PhD and co-authors examine the potential influence of conflicts of interest of committee members on these decisions and makes suggestions for minimizing this influence and keeping the decisions based on evidence.  Read article>>